Cargando…
Dual Effect of Combined Metformin and 2-Deoxy-D-Glucose Treatment on Mitochondrial Biogenesis and PD-L1 Expression in Triple-Negative Breast Cancer Cells
SIMPLE SUMMARY: Metformin and 2-deoxy-D-glucose are metabolic drugs with multiple and incompletely understood anti-cancer effects. Their combination can cause breast cancer cell detachment from the growth surface. Mitochondria are important for detached cell survival and metastasis, but how metformi...
Autores principales: | Repas, Jernej, Zupin, Mateja, Vodlan, Maja, Veranič, Peter, Gole, Boris, Potočnik, Uroš, Pavlin, Mojca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909901/ https://www.ncbi.nlm.nih.gov/pubmed/35267651 http://dx.doi.org/10.3390/cancers14051343 |
Ejemplares similares
-
Metabolic profiling of attached and detached metformin and 2-deoxy-D-glucose treated breast cancer cells reveals adaptive changes in metabolome of detached cells
por: Repas, Jernej, et al.
Publicado: (2021) -
Pre-Treatment Biomarkers of Anti-Tumour Necrosis Factor Therapy Response in Crohn’s Disease—A Systematic Review and Gene Ontology Analysis
por: Gole, Boris, et al.
Publicado: (2019) -
Omics data integration identifies ELOVL7 and MMD gene regions as novel loci for adalimumab response in patients with Crohn’s disease
por: Gorenjak, Mario, et al.
Publicado: (2021) -
Head and Neck Cancer Stem Cell-Enriched Spheroid Model for Anticancer Compound Screening
por: Goričan, Larisa, et al.
Publicado: (2020) -
Combined treatment with Metformin and 2-deoxy glucose induces detachment of viable MDA-MB-231 breast cancer cells in vitro
por: Bizjak, Maruša, et al.
Publicado: (2017)